ABSTRACT-We prepared poly (A)+ mRNA from bovine adrenal medulla and electro physiologically examined the expression of H1-histaminergic receptors in Xenopus laevis oocytes. Histamine dose-dependently induced inward currents in oocytes injected with the mRNA, but not in those injected with water or the non-injected oocytes. This response was also induced by H1-agonists and antagonized by Hl-antagonists, while both an H2-agonist and an antagonist had no effect. These results clearly demonstrate that H1-histaminergic receptors are functionally expressed in oocytes injected with exogenous mRNA.
Histamine is a widely occurring chemical mediator that has long been known as a neuroregulator, an inflammatory mediator and a factor involved in cardiac and gastrointestinal system regulation (1). Histamine's effects are believed to be mediated by specific surface receptors. Three histamine receptor subtypes, H1, H2, and H3, have been identified on the basis of their pharmacological properties (2). Histamine H1 receptors are known to be coupled to the phosphoinositide (PI) hydrolysis pathway, resulting in the mobilization of intracellular Ca 2+ . H2 receptors, on the other hand, are coupled to adenylate cyclase, which causes an increase in intracellular cyclic AMP. Although pharmacological and biochemical information of this kind has already been obtained, no report of a thorough histamine receptor purification and characterization has yet appeared. This is mainly due to the difficulty of solubilizing the receptors in their native form and the concentration of histamine receptors in tissues being very limited. Xenopus laevis oocytes have proven to be a useful system for the expression of receptors and ion channels from naturally occurring mRNA as well as from mRNA transcribed in vitro from cloned cDNA (3). To obviate the need for protein purification, we attempted to express H1 receptors in Xenopus oocytes by injecting exogenous mRNA extracted from tissues rich in H1 receptors. We particularly chose bovine adrenal medulla (AM) as the mRNA source, because the binding of histamine to bovine adrenal chromaffin cells is functionally coupled to the stimulation of PI metabolism and Ca 2+ mobilization (4 -7). We would like to report the expression of H1-histaminergic receptors in Xenopus oocytes injected with AM mRNA.
Histamine, mepyramine and niflumic acid were obtained from Sigma. d-Chlorpheniramine was purchased from Tokyo Kasei. lChlorpheniramine was donated by Schering.
All other histaminergic agonists and antagonists were generous gifts from Smith Klein and French.
Total RNA was extracted from AM according to the acid guanidium thiocyanate/ phenol/chloroform protocol (8) . Poly (A)+ mRNA was isolated by chromatography on oligo (dT)-cellulose. It was then solubilized by H20 at a concentration of 1 ,ug/,ul and stored at -80°C until use.
Injection of mRNA into Xenopus oocytes and electrophysiological testing were carried out as previously described (9) . Mature oocytes (stages V and VI) were enzymatically defolliculated through incubation in Ca2+-free frog Ringer solution containing 2 mg/ml collagenase (Wako Pure Chemical) for 3 hr at room temperature. mRNA-injected oocytes were maintained at 18°C for 1-3 days in sterile Barth's medium supplemented with 100 U/ml penicillin and 100,ug/ml streptomycin until the recordings. Whole-cell currents were recorded under voltage clamp at -60 mV. Oocytes challenge with histaminergic agonists was conducted by bath application in the presence or absence of antagonists.
More than 90% of the defolliculated oocytes injected with AM mRNA showed inward currents in response to 100,uM histamine. The mean latency of responses was 11 sec, excluding the "dead-space" time of the perfusion system. As illustrated in Fig. 1A , inward currents exhibited varied wave forms lasting more than 4 min. The magnitude of inward currents in responsive oocytes varied from frog to frog. However, the wave forms of the currents in oocytes from an individual frog were very similar, and the variability among oocytes was roughly less than 30%. None of the noninjected oocytes or those injected with water responded to histamine. These results indicate that functional histamine receptors can be expressed in oocytes by translation of exogenous AM mRNA.
When an injected oocyte was restimulated with histamine 5 min after ending its initial response, the second response was of almost the same magnitude and had a similar wave form (Fig. 1B) . However, the histamine-evoked inward current response was completely inhibited by pretreating the injected oocyte with niflumic acid (Fig. 1C) , a potent blocker of Ca 2+-activated Cl-channels in Xenopus oocytes (10) . This suggests that the current responses to histamine are caused by an increase in membrane Cl-conductance.
To characterize the properties of histamine receptors expressed in the oocytes injected with AM mRNA, we challenged the oocytes with various histamine agonists and measured subsequent responses electrophysiologically. To negate the inter-oocyte variability among current responses (Fig. 1A) , each oocyte was stimulated twice by histamine, initially at 100 ,uM and then at various concentrations. An interval of more than 5 min was established between stimulations to eliminate the effect of the first histamine challenge. Relative peak current responses (responses evoked by the second application of histamine to those by the first) were plotted over a concentraion range of 1 ,u M -1 mM. As shown in Fig. 2A , histamine induced a dose-dependent response with a half-maximal potentiation occurring at 10 ,uM. Similarly, several H1-and H2-agonists were tested for activity in inducing inward currents in injected oocytes. As shown in Fig.  2A , at 1 mM, the Hi-agonist 2-(2-thiazolyl)-ethylamine expressed a potency equal to histamine. Other H1-agonists, 2-methyl-histamine and 2-(2-pyridyl)ethylamine, which have about 10% the potency of histamine, were also capable of evoking inward currents. However, the H2-agonist, impromidine, which is 50 times as potent as histamine, did not evoke a response at 100 ,u M. These results demonstrate that histaminergic receptors expressed in the oocytes injected with AM mRNA are of the H1-type.
To confirm the expression of H1 receptors in oocytes injected with AM mRNA, we stimulated the oocytes with 100 ,uM histamine in the presence of various concentrations of histaminergic antagonists. Figure 2B shows the dose-dependent attenuation of histamineevoked currents with simultaneous application of the H1-antagonist mepyramine. At 1 ,uM, complete inhibition of the response was observed with mepyramine, but not with the H2-antagonist famotidine. The K; value of mepyramine was 4.5 nM, which is comparable to that of mepyramine for the histamineinduced PI response in chromaffin cells (6) . Consistent with the previous report (11) , the inhibition by chlorpheniramine was stereospecific (Fig. 2C) ; an approximately 20-fold higher concentration of 1-chlorpheniramine was necessary to obtain the same inhibitory effect peripheral tissues. Almost all neurotransmitter and hormone receptors expressed in oocytes and detected by electrophysiological methods to date, such as 5-HT1c and neurokinin receptors, have been coupled to inositol trisphosphate generation via a GTP-binding protein. Subsequent intracellular Ca 2+ mobilization evokes the opening of Ca t+-dependent Cl-channels. Since the H1 receptor is coupled to PI metabolism, the histamine-evoked inward currents reported here also appear to be due to activation of Cat+-dependent Cl channels (Fig. 1C) . Accumulating evidence indicates the involvement of a GTP-binding protein in signal transduction by H1 receptor stimulation (12) (13) (14) (15) . These common biochemical and electrophysiological properties between histamine response and responses via other receptors lead us to believe that H1 receptors may be a member of the superfamily of GTP-binding protein-coupled receptors (3). The present study will provide a system particularly suited to cDNA cloning of H1 receptors. This may lead to further understanding of physiological histamine roles in the central nervous system and peripheral tissues on a molecular level.
